Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection (Q45884517)

17 December 2017

title

Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection (English)

1 reference

17 December 2017

main subject

hepatocellular carcinoma

1 reference

Xiang Liu

1 reference

17 December 2017

Peikun Tian

1 reference

17 December 2017

Yizhi Yu

1 reference

17 December 2017

Ming Yao

1 reference

17 December 2017

Xuetao Cao

1 reference

17 December 2017

Jianren Gu

1 reference

17 December 2017

language of work or name

1 reference

1 January 2002

1 reference

17 December 2017

published in

Cancer Gene Therapy

1 reference

17 December 2017

volume

1 reference

17 December 2017

issue

1 reference

17 December 2017

page(s)

100-108

1 reference

17 December 2017

HER2-targeted gene transfer

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Gene delivery by an epidermal growth factor/DNA polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

A novel receptor-targeted gene delivery system for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

A novel gene delivery system targeting cells expressing VEGF receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Combined chemokine and cytokine gene transfer enhances antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Enhanced adjuvant effect of granulocyte-macrophage colony-stimulating factor plus interleukin-12 compared with either alone in vaccine-induced tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Local and systemic effects after adenoviral transfer of the murine granulocyte-macrophage colony-stimulating factor gene into mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Immunohistochemical analysis of human CD5 positive B cells: mantle cells and mantle cell lymphoma are not equivalent in terms of CD5 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

“Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Locally advanced, unresectable non-small cell lung cancer: new treatment strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Liver-directed gene therapy: promises, problems and prospects at the turn of the century

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Uses of granulocyte-macrophage colony-stimulating factor in vaccine development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Cell-cycle arrest versus cell death in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

p53-dependent apoptosis suppresses tumor growth and progression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Apoptosis in cancer therapy: crossing the threshold

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Preclinical development of human granulocyte-macrophage colony-stimulating factor-transfected melanoma cell vaccine using established canine cell lines and normal dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700400

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700400

1 reference

17 December 2017

Dimensions Publication ID

1032964644

0 references

1 reference

17 December 2017